ISIN
GB00BNLPYF73
Symbol
SPI

Spire Healthcare Group Target price 2026 - Analyst rating & recommendation

Spire Healthcare Group Classifications & Recommendation

Buy
92%
Hold
8%

Spire Healthcare Group Price Target

Target Price £2.55
Price £2.46
Potential
Number of Estimates 8
8 Analysts have issued a price target Spire Healthcare Group 2027 . The average Spire Healthcare Group target price is £2.55. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 12 Analysts recommend Spire Healthcare Group to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Spire Healthcare Group stock has an average upside potential 2027 of . Most analysts recommend the Spire Healthcare Group stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion £ 1.58 1.67
4.54% 5.52%
EBITDA Margin 9.33% 16.93%
1.33% 81.45%
Net Margin 1.04% 2.46%
38.24% 136.97%

8 Analysts have issued a sales forecast Spire Healthcare Group 2026 . The average Spire Healthcare Group sales estimate is

£1.7b
unlock
. This is
5.52% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
£1.8b 11.79%
unlock
, the lowest is
£1.5b 2.39%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 £1.6b 4.54%
2026
£1.7b 5.52%
unlock
2027
£1.8b 5.34%
unlock
2028
£1.8b 4.04%
unlock

8 Analysts have issued an Spire Healthcare Group EBITDA forecast 2026. The average Spire Healthcare Group EBITDA estimate is

£282m
unlock
. This is
91.51% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
£294m 99.17%
unlock
, the lowest is
£263m 78.59%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 £147m 3.15%
2026
£282m 91.51%
unlock
2027
£316m 12.06%
unlock
2028
£334m 5.66%
unlock

EBITDA Margin

2025 9.33% 1.33%
2026
16.93% 81.45%
unlock
2027
18.01% 6.38%
unlock
2028
18.29% 1.55%
unlock

8 Spire Healthcare Group Analysts have issued a net profit forecast 2026. The average Spire Healthcare Group net profit estimate is

£41.0m
unlock
. This is
149.82% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
£65.6m 299.70%
unlock
, the lowest is
£24.3m 48.29%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 £16.4m 35.43%
2026
£41.0m 149.82%
unlock
2027
£63.7m 55.46%
unlock
2028
£67.0m 5.12%
unlock

Net Margin

2025 1.04% 38.24%
2026
2.46% 136.97%
unlock
2027
3.63% 47.56%
unlock
2028
3.66% 0.83%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share £ 0.04 0.10
33.33% 150.00%
P/E 24.14
EV/Sales 1.36

8 Analysts have issued a Spire Healthcare Group forecast for earnings per share. The average Spire Healthcare Group EPS is

£0.10
unlock
. This is
150.00% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
£0.16 300.00%
unlock
, the lowest is
£0.06 50.00%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 £0.04 33.33%
2026
£0.10 150.00%
unlock
2027
£0.16 60.00%
unlock
2028
£0.17 6.25%
unlock

P/E ratio

Current 61.38 25.46%
2026
24.14 60.67%
unlock
2027
15.53 35.67%
unlock
2028
14.77 4.89%
unlock

Based on analysts' sales estimates for 2026, the Spire Healthcare Group stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.44 2.04%
2026
1.36 5.48%
unlock
2027
1.29 5.07%
unlock
2028
1.24 3.89%
unlock

P/S ratio

Current 0.63 2.86%
2026
0.59 5.23%
unlock
2027
0.56 5.08%
unlock
2028
0.54 3.88%
unlock

Current Spire Healthcare Group Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Deutsche
Locked
Locked
Locked May 15 2026
Analyst Rating Date
Locked
Deutsche:
Locked
Locked
May 15 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today